Conclusions
Biomarkers of acute myocardial injury play an important role in predicting worsening prognosis for COVID-19 patients with and without myocardial injury. Elevated TnT, CK-MB and NT-pro-BNP levels correlate with more severe symptoms of COVID-19. There are in fact not only predictive of disease severity, but are also helpful for therapeutic management, based on drugs preventing the activation of coagulation processes. It’s important, above all, to identify a laboratory score, made by hematological, inflammatory, biochemical (above all TnT, NT-pro-BNP and CK-MB) and immunological parameters, may help to stratify COVID-19 positive patients into risk categories for deciding therapeutic management, thus avoiding cardiac compromise which, as we have previously analyzed, is an indication of a poor prognosis.